Ultragenyx Pharmaceutical Inc. RARE
$24.80
▲ +1.54% 24H
About
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and ultra-rare genetic diseases. Ultragenyx Pharmaceutical Inc. currently markets medicines for conditions such as X-linked hypophosphatemia, mucopolysaccharidosis VII, and certain metabolic disord…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,294
TickerRARE
Statistics
Market Cap$2.44B
Revenue (TTM)$673.0M
Net Income-$575.0M
Net Margin-85.4%
EPS$-6.10
P/E-4.11
P/S3.38
P/B-10.53
EV/EBITDA-6.14
ROE787.7%
Dividend Yield—
Price$24.80
Data: Twelve Data · Revenue = mcap / P/S